Antiretroviral therapy in pregnancy: a 2023 review of the literature
AN Goulding, K Meeks, L Shay, S Casey… - Current HIV/AIDS …, 2024 - Springer
Abstract Purpose of Review Selection of antiretroviral therapy during pregnancy must
consider maternal physiology and resulting pharmacokinetic changes in pregnancy …
consider maternal physiology and resulting pharmacokinetic changes in pregnancy …
[HTML][HTML] Advancing HIV drug resistance technologies and strategies: insights from South Africa's experience and future directions for resource-limited settings
Monitoring of HIV drug resistance (HIVDR) remains critical for ensuring countries attain and
sustain the global goals for ending HIV as a public health threat by 2030. On an individual …
sustain the global goals for ending HIV as a public health threat by 2030. On an individual …
Development and emerging trends of drug resistance mutations in HIV: a bibliometric analysis based on CiteSpace
X Chen, X Chen, Y Lai - Frontiers in Microbiology, 2024 - frontiersin.org
Background Antiretroviral therapy has led to AIDS being a chronic disease. Nevertheless,
the presence of constantly emerging drug resistance mutations poses a challenge to clinical …
the presence of constantly emerging drug resistance mutations poses a challenge to clinical …
Advancing disease genomics beyond COVID-19 and reducing health disparities: what does the future hold for Africa?
C Ibe, AA Otu, NP Mnyambwa - Briefings in Functional …, 2023 - academic.oup.com
The COVID-19 pandemic has ushered in high-throughput sequencing technology as an
essential public health tool. Scaling up and operationalizing genomics in Africa is crucial as …
essential public health tool. Scaling up and operationalizing genomics in Africa is crucial as …
[HTML][HTML] HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
GF Nzengui-Nzengui, G Mourembou… - BMC Infectious …, 2024 - Springer
Introduction In 2022, the WHO reported that 29.8 million people around the world were living
with HIV (PLHIV) and receiving antiretroviral treatment (ART), including 25 375 people in …
with HIV (PLHIV) and receiving antiretroviral treatment (ART), including 25 375 people in …
[HTML][HTML] HIV-1 subtype diversity, phylogenetic analysis and study of drug resistance in strains circulating in the Ural Federal District
MV Piterskiy, AG Gusev, OA Khodakov… - Journal of …, 2022 - microbiol.crie.ru
Abstract Introduction. Ural Federal District (UFD) has been one of the most HIV-affected
areas in the Russian Federation during past 20 years. The total number of people living with …
areas in the Russian Federation during past 20 years. The total number of people living with …
[HTML][HTML] Identification of human immunodeficiency virus-1 E protein-targeting lead compounds by pharmacophore based screening
Objectives: To identify potential compounds by seeking the knowledge of molecular
interactions between human immunodeficiency virus (HIV) glycoprotein (gp) 120 protein and …
interactions between human immunodeficiency virus (HIV) glycoprotein (gp) 120 protein and …
[HTML][HTML] Identification of HIV-1 subtype CRF18_cpx in a patient with multidrug resistance in KwaZulu-Natal, South Africa: An epidemiological worry?
The most common HIV-1 subtype in South Africa is subtype C, and detection of other
subtypes is rare. We report the first known case of HIV-1 subtype CRF18_cpx identified in …
subtypes is rare. We report the first known case of HIV-1 subtype CRF18_cpx identified in …
[HTML][HTML] Разнообразие субтипов, филогенетический анализ и изучение лекарственной устойчивости штаммов ВИЧ-1, циркулирующих в Уральском …
МВ Питерский, АГ Гусев, ОА Ходаков… - Журнал …, 2022 - cyberleninka.ru
Введение. Уральский федеральный округ (УФО) является одной из наиболее
эпидемически неблагополучных территорий в Российской Федерации по ВИЧ …
эпидемически неблагополучных территорий в Российской Федерации по ВИЧ …
[PDF][PDF] Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa's Experience and Future Directions for Resource-Limited Settings …
Monitoring of HIV drug resistance (HIVDR) remains critical for ensuring countries attain and
sustain the global goals for ending HIV as a public health threat by 2030. On an individual …
sustain the global goals for ending HIV as a public health threat by 2030. On an individual …